GleamWall
中文EN

EMBC Embecta Corp.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1872789 · Fiscal year ends 09/30

Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-7.6%
TTM net income YoY4.7%
TTM EPS YoY3.5%
Revenue 3-yr CAGR-2.9%
Net income 3-yr CAGR22.8%

Margins

Gross margin59.0%
Operating margin21.9%
Net margin8.6%
FCF margin16.2%
EBITDA margin26.3%

Returns

ROE—
ROA7.2%
ROIC (approx.)26.2%
Asset turnover0.84x

Leverage & solvency

Liabilities / assets148.4%
Debt / equity—
Current ratio1.68x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.99x
Accruals ratio-7.1%
Payout ratio31.1%
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-09-30FY20242024-09-30
Income statement
Revenue$1.08B$1.12B
Cost of revenue$403.60M$387.90M
Gross profit$676.80M$735.20M
R&D expense$37.30M$78.80M
SG&A expense$332.00M$365.10M
Operating income$242.10M$166.80M
Pretax income$136.30M$44.20M
Income tax$40.90M-$34.10M
Net income$95.40M$78.30M
EBITDA$282.80M$203.00M
EPS (basic)1.641.36
EPS (diluted)1.621.34
Dividends declared per share0.600.60
Weighted avg. shares (diluted)58.91M58.33M
Balance sheet
Cash & equivalents$225.50M$274.20M
Receivables$145.60M$193.00M
Inventory$178.60M$171.50M
Current assets$631.40M$761.00M
PP&E, net$257.20M$290.40M
Goodwill$15.40M$15.60M
Intangibles$7.00M$8.10M
Total assets$1.09B$1.29B
Current liabilities$261.50M$374.00M
Short-term debt$9.50M$9.50M
Long-term debt$1.39B$1.57B
Total debt$1.40B$1.57B
Total liabilities$1.74B$2.02B
Shareholders' equity-$650.60M-$738.30M
Net debt$1.17B$1.30B
Shares outstanding58.50M57.71M
Cash flow statement
Operating cash flow$191.70M$35.70M
Capital expenditure$9.30M$15.80M
Free cash flow$182.40M$19.90M
Investing cash flow-$9.30M-$15.80M
Financing cash flow-$226.70M-$73.40M
Depreciation & amortization$40.70M$36.20M
Stock-based compensation$31.60M$26.30M
Dividends paid$35.00M$34.50M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.